Characteristic | TEVAR n=105 (no, %) | Surgical repair n=22 (no, %) | Hybrid repair n=49, (no, %) | Medical management n=251 (no, %) | All patients n=427 (no, %) | P value |
Age (median, IQR) | 41 (27–55) | 48 (33–65) | 34 (26–49) | 53 (34–65) | 46 (30–62) | <0.0001 |
Sex—female | 23 (21.9) | 6 (27.3) | 10 (20.4) | 77 (30.7) | 116 (27.2) | 0.24 |
Rurality (no, %) | ||||||
Rural (population <10 000) | 15–19* | 1–5* | 7 (14.3) | 52–56* | 81–85* | 0.59 |
Urban (population >10 000) | 84–88* | 17–21* | 42 (85.7) | 194 (77.3) | 341 (79.9) | |
Missing | 1–5* | 0 (0.0) | 0 (0.0) | 1–5* | 1–5* | |
Elixhauser comorbidity index score (no, %) | ||||||
0 | 50 (47.6) | 6 (27.3) | 18 (36.7) | 132 (52.6) | 206 (48.2) | 0.04 |
1 | 34 (32.4) | 9 (40.9) | 22 (44.9) | 61 (24.3) | 126 (29.5) | |
2 or more | 21 (20.0) | 7 (31.8) | 9 (18.4) | 58 (23.1) | 95 (22.2) |
*Cells with less than six patients are suppressed to protect patient privacy.
TEVAR, thoracic endovascular aortic repair.